secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2026-05-12T21:01:51+00:00
Accession:  0001104659-26-059484
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie shareholders re-elect all Class II directors; reject supermajority elimination and independent chair proposal
--------------------------------------------------------------------------------

- All four Class II directors elected: Davis (1.22B for), Meyer (1.28B), Michael (1.22B), Waddell (1.23B).
- Ratification of EY as auditor approved with 1.52B votes for, 23.8M against.
- Advisory say-on-pay approved with 1.23B for, 69.3M against.
- Proposal to eliminate supermajority voting did not pass: 1.29B for (needed supermajority).
- Stockholder proposal for independent chair rejected: 515.6M for, 787.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465926059484/0001104659-26-059484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465926059484/tm2614276d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-059484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer